Upgrade to SI Premium - Free Trial

Regeneron (REGN)

827.72 -15.75 (1.87%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/29/26)

Latest Headlines

RBC Capital Reiterates Sector Perform Rating on Regeneron Pharma (REGN) September 1, 2026 8:56 AM - StreetInsider Form 4 REGENERON PHARMACEUTICAL For: Aug 19 Filed by: LAROSA JOSEPH J August 21, 2026 4:01 PM - SEC Filing Form N-PX REGENERON PHARMACEUTICAL For: Jun 30 August 20, 2026 4:12 PM - SEC Filing Form 4 REGENERON PHARMACEUTICAL For: Aug 18 Filed by: Fenimore Christopher R. August 20, 2026 4:02 PM - SEC Filing Regeneron Announces Investor Conference Presentations August 19, 2026 4:05 PM - StreetInsider FDA approves Regeneron's Pasatru for rare bone disorder FOP August 19, 2026 1:58 PM - StreetInsider Pasatru™ (garetosmab-grts) First and Only FDA-approved Treatment Demonstrating Reduction in New Heterotopic Ossification (HO) Lesions and Clinician-Assessed Flare-ups in a Placebo-controlled Trial i August 19, 2026 1:58 PM - Globe NewsWire Regeneron Pharma (REGN) PT Raised to $756 at Bernstein SocGen Group August 14, 2026 9:28 AM - StreetInsider Form 4 REGENERON PHARMACEUTICAL For: Aug 10 Filed by: Guarini Kathryn August 12, 2026 4:17 PM - SEC Filing Form 4 REGENERON PHARMACEUTICAL For: Aug 10 Filed by: Zoghbi Huda Y August 12, 2026 4:15 PM - SEC Filing Form 144 REGENERON PHARMACEUTICAL Filed by: Zoghbi Huda Y August 10, 2026 4:14 PM - SEC Filing Form 144 REGENERON PHARMACEUTICAL Filed by: Guarini Kathryn August 10, 2026 4:12 PM - SEC Filing Form 13F-HR REGENERON PHARMACEUTICAL For: Jun 30 August 7, 2026 4:13 PM - SEC Filing Regeneron Pharma (REGN) PT Raised to $800 at BMO Capital July 31, 2026 8:59 AM - StreetInsider Regeneron Pharma (REGN) PT Raised to $750 at Wells Fargo July 31, 2026 8:35 AM - StreetInsider Regeneron Pharma (REGN) PT Raised to $737 at RBC Capital July 31, 2026 8:22 AM - StreetInsider Regeneron Pharma (REGN) PT Raised to $758 at Morgan Stanley July 31, 2026 8:01 AM - StreetInsider Regeneron Pharma (REGN) PT Raised to $761 at Baird July 31, 2026 7:21 AM - StreetInsider Regeneron Pharma (REGN) PT Raised to $772 at Truist Securities July 31, 2026 7:10 AM - StreetInsider Regeneron Awards $150,000 to Winners of the 2026 Regeneron Prize for Creative Innovation July 31, 2026 7:00 AM - StreetInsider Regeneron Pharma (REGN) PT Raised to $891 at BofA Securities July 30, 2026 1:36 PM - StreetInsider Regeneron (REGN) Tops Q2 EPS by 371c July 30, 2026 6:59 AM - StreetInsider Form 10-Q REGENERON PHARMACEUTICAL For: Jun 30 July 30, 2026 6:52 AM - SEC Filing Form 8-K REGENERON PHARMACEUTICAL For: Jul 30 July 30, 2026 6:49 AM - SEC Filing Tessera Therapeutics names former Merck executive as new CEO July 23, 2026 1:00 PM - StreetInsider Tessera Therapeutics Appoints Joseph Romanelli as President and Chief Executive Officer July 23, 2026 1:00 PM - PR NewsWire Regeneron Pharma (REGN) PT Raised to $1,000 at Guggenheim July 21, 2026 6:45 AM - StreetInsider Regeneron Pharma (REGN) Reiterated at Overweight by Cantor Fitzgerald July 13, 2026 7:41 AM - StreetInsider Regeneron Pharma (REGN) PT Lowered to $854 at Piper Sandler July 9, 2026 7:11 AM - StreetInsider Regeneron Pharma (REGN) PT Lowered to $730 at Morgan Stanley July 8, 2026 8:08 AM - StreetInsider Form 4 REGENERON PHARMACEUTICAL For: Jul 02 Filed by: RYAN ARTHUR F July 7, 2026 4:05 PM - SEC Filing Regeneron Pharma (REGN) PT Lowered to $696 at RBC Capital July 7, 2026 7:55 AM - StreetInsider Regeneron Pharma (REGN) PT Lowered to $769 at Truist Securities July 7, 2026 7:09 AM - StreetInsider Form 8-K REGENERON PHARMACEUTICAL For: Jul 06 July 6, 2026 7:01 AM - SEC Filing Regeneron Pharma (REGN) PT Lowered to $750 at Cantor Fitzgerald on Negative Eylea Optics July 6, 2026 6:46 AM - StreetInsider Regeneron Pharma (REGN) PT Lowered to $800 at HSBC July 6, 2026 1:35 AM - StreetInsider Form 144 REGENERON PHARMACEUTICAL Filed by: RYAN ARTHUR F July 2, 2026 5:46 PM - SEC Filing FDA selects 7 companies for domestic drug manufacturing pilot June 29, 2026 4:20 PM - StreetInsider From Vaccines to Therapeutics; How Biotech Is Addressing the Ebola Outbreak June 26, 2026 7:02 AM - StreetInsider Regeneron to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast June 25, 2026 4:05 PM - StreetInsider Cemdisiran Regulatory Submissions Accepted for Review by FDA and EMA for the Treatment of Generalized Myasthenia Gravis (gMG) June 22, 2026 7:00 AM - StreetInsider Form 8-K REGENERON PHARMACEUTICAL For: Jun 12 June 17, 2026 4:06 PM - SEC Filing Full Article List